Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial

Xuan Yi Wang, Syed Faisal Mahmood, Fang Jin, Wee Kooi Cheah, Muhammad Ahmad, Mian Amjad Sohail, Waheed Ahmad, Vijaya K. Suppan, Muneeba Ahsan Sayeed, Shobha Luxmi, Aik Howe Teo, Li Yuan Lee, Yang Yang Qi, Rong Juan Pei, Wei Deng, Zhong Hui Xu, Jia Ming Yang, Yan Zhang, Wu Xiang Guan, Xiong Yu

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology